191 related articles for article (PubMed ID: 22623208)
21. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.
Rosser SPA; Lee S; Kohli S; Keogh SJ; Chung J; O'Brien T; Fraser C; McLachlan AJ; Shaw PJ; Nath CE
Br J Clin Pharmacol; 2023 Apr; 89(4):1413-1424. PubMed ID: 36369677
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
Bonate PL; Floret S; Bentzen C
Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796
[TBL] [Abstract][Full Text] [Related]
24. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.
Kawakatsu S; Nikanjam M; Lin M; Le S; Saunders I; Kuo DJ; Capparelli EV
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1339-1348. PubMed ID: 31586225
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
Gastine S; Lehrnbecher T; Müller C; Farowski F; Bader P; Ullmann-Moskovits J; Cornely OA; Groll AH; Hempel G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038273
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism.
Röshammar D; Huang F; Albisetti M; Bomgaars L; Chalmers E; Luciani M; Halton J; Mitchell LG; Bergstrand M; Ibrahim MMA; Joseph D; Tartakovsky I; Gropper S; Brueckmann M; Brandão LR
J Thromb Haemost; 2021 May; 19(5):1259-1270. PubMed ID: 33636042
[TBL] [Abstract][Full Text] [Related]
31. Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
Li L; Wu H; Chen Y; Yuan H; Wu J; Wu X; Zhang Y; Cao G; Guo B; Wu J; Zhao M; Zhang J
Clin Ther; 2020 May; 42(5):818-829. PubMed ID: 32389326
[TBL] [Abstract][Full Text] [Related]
32. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling.
Jaber MM; Brundage RC
J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):123-132. PubMed ID: 36617366
[TBL] [Abstract][Full Text] [Related]
33. Hydromorphone population pharmacokinetics in pediatric surgical patients.
Balyan R; Dong M; Pilipenko V; Geisler K; Vinks AA; Chidambaran V
Paediatr Anaesth; 2020 Oct; 30(10):1091-1101. PubMed ID: 32702184
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of subcutaneous tunneling for prevention of bacterial colonization of femoral central venous catheters in critically ill children.
Nahum E; Levy I; Katz J; Samra Z; Ashkenazi S; Ben-Ari J; Schonfeld T; Dagan O
Pediatr Infect Dis J; 2002 Nov; 21(11):1000-4. PubMed ID: 12442019
[TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis.
Zühlsdorf M; Bhattaram VA; Campioni M; Krösser S; Derendorf H; Kovar A
J Clin Pharmacol; 2014 Dec; 54(12):1391-9. PubMed ID: 24911832
[TBL] [Abstract][Full Text] [Related]
36. NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.
Periclou AP; Avramis VI
Cancer Chemother Pharmacol; 1996; 39(1-2):42-50. PubMed ID: 8995498
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors.
Garg A; Quartino A; Li J; Jin J; Wada DR; Li H; Cortés J; McNally V; Ross G; Visich J; Lum B
Cancer Chemother Pharmacol; 2014 Oct; 74(4):819-29. PubMed ID: 25119184
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of fluconazole in young infants.
Wade KC; Wu D; Kaufman DA; Ward RM; Benjamin DK; Sullivan JE; Ramey N; Jayaraman B; Hoppu K; Adamson PC; Gastonguay MR; Barrett JS;
Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patients.
Zheng B; Yu XQ; Greth W; Robbie GJ
Br J Clin Pharmacol; 2016 May; 81(5):918-28. PubMed ID: 26659791
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
